Join us in this enlightening episode as we delve into the intersection of pharmacogenetics and pregnancy with our esteemed guest, Dr. Ina Liko. With residency and fellowship training in pharmacogenomics along with years of experience in clinical experience ranging from patient-specific to systemwide applications, Dr. Liko, the Director of Clinical Pharmacogenomics Operations at RxGenomix, is at the forefront of innovation in improving patient outcomes.
We explore the vital role pharmacogenetic information plays in enhancing pregnancy outcomes. From preconception to postpartum care, Dr. Liko guides us through the clinical applications of pharmacogenomics, touching upon various medication classes and their impact on maternal health. Whether it's optimizing IVF protocols, managing hyperemesis, addressing pain management, or tackling postpartum depression, we uncover how tailored medication strategies can significantly improve maternal and fetal well-being.
Dr. Liko sheds light on the intricacies of interpreting genetic test results to determine appropriate medication doses, empowering both patients and providers with actionable insights. We also discuss overcoming barriers in implementing pharmacogenetic testing within healthcare systems, highlighting the evolving landscape and the importance of pharmacist involvement in precision medicine in pregnancy.
To dive deeper into this topic, visit Dr. Liko's PGx Clinical Pearls at https://rxgenomix.com/insights-news/clinical-pearls/).
Connect with Dr. Plummer at https://www.linkedin.com/in/daniellerplummer/)
